You know this is a very, very exciting time to be coming into medicine. I think for cellular therapy, it’s really being studied even beyond the hematology and medical oncology space into other diseases where the immune system plays a role. And so for young investigators coming in, whether they’re focused on, interested in a particular disease and trying to see if there’s a role for cell therapy in that, or they’re very interested in cell therapy and more open to identifying ways to make cell therapy work better and seeing what disease you know that could be used for, I think either one would be very good approaches...
You know this is a very, very exciting time to be coming into medicine. I think for cellular therapy, it’s really being studied even beyond the hematology and medical oncology space into other diseases where the immune system plays a role. And so for young investigators coming in, whether they’re focused on, interested in a particular disease and trying to see if there’s a role for cell therapy in that, or they’re very interested in cell therapy and more open to identifying ways to make cell therapy work better and seeing what disease you know that could be used for, I think either one would be very good approaches. So it’s really the options are wide open. I don’t think there’s necessarily one track or one, you know, best track to get into cell therapy. Similarly, some people may be interested in more benchtop work or more, what we call dry science, you know, informatics and AI, or clinical application. So there’s a role now that cell therapy is in standard of care practice for all different aspects of clinical and translational and basic science to advance the field. So I think it is very much kind of merging what the young investigator is really passionate about to build their research and see where’s that opportunity to use that in the cell therapy field.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.